Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00263458 · ClinicalTrials.gov registry record · Phase 4
Integrating Buprenorphine Into the SFGH AIDS Program
A Phase 4 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 37
- Enrollment target
NCT00263458 is a Phase 4 study that has completed, run by University of California, San Francisco. The registered enrollment target is 37 participants.
The verdict
NCT00263458, a Phase 4 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the feasibility, cost, and effectiveness of a model of care designed to integrate buprenorphine treatment for opioid dependence into the HIV primary care clinics at the UCSF Positive Health Program.
Interventions
- OTHER Integrated office-based buprenorphine treatment for opioid dependence in an HIV primary care setting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2005-12 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00263458
The ClinicalTrials.gov registry entry for NCT00263458 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Integrated office-based buprenorphine treatment for opioid dependence in an HIV primary care setting is the first listed.
NCT00263458 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00263458 about?
NCT00263458 is a clinical study titled "Integrating Buprenorphine Into the SFGH AIDS Program". The purpose of this study is to assess the feasibility, cost, and effectiveness of a model of care designed to integrate buprenorphine treatment for opioid dependence into the HIV primary care clinics at the UCSF Positive Health Program.
What is the current status of trial NCT00263458?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 37 participants. The study started on 2005-12. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00263458?
The interventions under investigation include: Integrated office-based buprenorphine treatment for opioid dependence in an HIV primary care setting (OTHER).
Who is sponsoring clinical trial NCT00263458?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.